Belantamab mafodotin provides a community-friendly BCMA-directed therapy option for relapsed/refractory myeloma, says Hearn ...

Consolidative radiotherapy (RT) can improve outcomes in patients with diffuse large B-cell lymphoma (DLBCL), according to a ...

Belantamab mafodotin, a BCMA-targeting ADC, is approved for relapsed/refractory multiple myeloma after two prior therapies, ...

Elinzanetant offers a promising alternative to hormone therapy for women seeking relief from menopause symptoms, said JoAnn V ...

AI-powered mammography is enhancing breast cancer screening and early detection through cutting-edge radiology insights.

They review common resistance mechanisms, such as secondary mutations (T790M, C797S), pathway activation, and histologic ...

Investing in proper masks that don't have snapping elastic on them and do not obstruct peripheral vision can help to protect ...

Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, ...

Panelists discuss how understanding EGFR mutations has transformed the treatment landscape for non–small cell lung cancer ...

Ken Cohen, MD, FACP, discusses how clinicians can support patients after a cognitive screening to identify meaningful next ...

Assessing all available nonhormonal and hormonal therapies for vasomotor symptoms helps empower women to make informed ...

Perimenopausal women face increased pregnancy-related risks, necessitating continued contraceptive use until menopause is confirmed. Healthy women can use combination hormonal contraceptives until mid ...